2019 opens to biggest pharma deal ever; Pfizer announces shutdown of two plants in India

If 2018 proved to be a big year for pharma deals, 2019 promises to be even bigger. The US government may have been partially shutdown, but some pharma companies were working through the holidays. The year opened with Bristol Myers Squibb acquirin...

2019 opens to biggest pharma deal ever; Pfizer announces shutdown of two plants in India

10 Jan 2019

Radio Compass

PharmaCompass.com

View: 1322

Read More

FDA proposes limits on ‘sartan’ nitrosamine impurities; Text messages add new twist to US generic price fixing litigation

In our final Phispers of 2018, we bring you news on how the big pharmaceutical companies in the US plan to ring in the new year with price hikes. In the price fixing case, three drugmakers are being accused of working in collusion to hike the price...

FDA proposes limits on ‘sartan’ nitrosamine impurities; Text messages add new twist to US generic price fixing litigation

27 Dec 2018

Radio Compass

PharmaCompass.com

View: 1565

Read More

Pfizer, GSK to merge consumer health units; J&J stock plummets after talc expose

The world of pharmaceuticals saw an eventful week when Pfizer and GSK decided to combine their consumer health units. The duo plans to demerge this consumer division after three years, through a UK stock market listing. An investigative report re...

Pfizer, GSK to merge consumer health units; J&J stock plummets after talc expose

20 Dec 2018

Radio Compass

PharmaCompass.com

View: 944

Read More

PharmaFlow in November: Biopharma stock slump continues as dealmaking picks up

The Nasdaq Biotechnology Index tumbled almost 14 percent in October 2018 and is currently (as of December 19, 2018) down 19 percent from its October 1, 2018 high. Although it looks like the biopharma sector is heading for a volatile 2019, the...

PharmaFlow in November:  Biopharma stock slump continues as dealmaking picks up

20 Dec 2018

Radio Compass

PharmaCompass.com

View: 557

Read More

America’s generic price fixing probe widens to 300 drugs; Rift between Ranbaxy’s Singh brothers gets physical

This week, Phispers brings you news from the US, India, China and France. In the US, the government’s probe into the alleged generic drug price fixing has now been expanded to include 300 drugs and 16 companies. In India, the slugfest betwe...

America’s generic price fixing probe widens to 300 drugs; Rift between Ranbaxy’s Singh brothers gets physical

13 Dec 2018

Radio Compass

PharmaCompass.com

View: 1257

Read More

Valsartan may have been contaminated since 2011, says FDA warning letter to Huahai

Since July this year, a host of high blood pressure drugs got recalled globally once both the US Food and Drug Administration (FDA) and regulators in Europe learned that the valsartan API made by China’s Zhejiang Huahai Pharmaceuticals co...

Valsartan may have been contaminated since 2011, says FDA warning letter to Huahai

13 Dec 2018

Radio Compass

PharmaCompass.com

View: 701

Read More

Bayer to cut 12,000 jobs; GSK buys cancer drugmaker Tesaro for US$ 5 billion

This week, Phispers has news on German drug major Bayer, which has drawn out a revamp plan that includes plans to slash 12,000 jobs worldwide and restructuring of its R&D business. British drug major GSK vaulted into the commercial oncology mar...

Bayer to cut 12,000 jobs; GSK buys cancer drugmaker Tesaro for US$ 5 billion

06 Dec 2018

Radio Compass

PharmaCompass.com

View: 1503

Read More

Expose on medical device failures and outrage over birth of genetically-edited babies in China grips pharma world

This week, Phispers tells you how an exposé by the International Consortium of Investigative Journalists (ICIJ) on medical device failures prodded the FDA to overhaul its approval process. Revelation by a Chinese researcher on the birth of...

Expose on medical device failures and outrage over birth of genetically-edited babies in China grips pharma world

29 Nov 2018

Radio Compass

PharmaCompass.com

View: 840

Read More

PharmaFlow in October: Deal making picks up; Pharma companies invest in capacity building

The year 2018 has witnessed a record-setting pace in approvals of new drugs. By early November, the US Food and Drug Administration (FDA) had approved 48 new drugs, as compared to a total of 46 new drugs approved in calendar 2017. This year, the ...

PharmaFlow in October: Deal making picks up; Pharma companies invest in capacity building

29 Nov 2018

Radio Compass

PharmaCompass.com

View: 540

Read More

Mylan’s troubles run deep: US plant receives warning letter; EU suspends valsartan certificate of suitability

In August this year, American generic drug major Mylan posted disappointing second-quarter results and slashed its full-year guidance. During its earnings call, the company had said it has formed a strategic review committee to look...

Mylan’s troubles run deep: US plant receives warning letter; EU suspends valsartan certificate of suitability

22 Nov 2018

Radio Compass

PharmaCompass.com

View: 1426

Read More

PharmaCompass